258 results on '"Warner, Andrew"'
Search Results
2. A randomized phase III trial of stereotactic ablative radiotherapy for patients with up to 10 oligometastases and a synchronous primary tumor (SABR-SYNC): study protocol
3. Augmentation of tumor expression of HLA-DR, CXCL9, and CXCL10 may improve olfactory neuroblastoma immunotherapeutic responses
4. Abcg2a is the functional homolog of human ABCG2 expressed at the zebrafish blood–brain barrier
5. Single vs. multiple fraction non-inferiority trial of stereotactic ablative radiotherapy for the comprehensive treatment of oligo-metastases/progression: SIMPLIFY-SABR-COMET
6. Radiotherapy Versus Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma: Final Results of the ORATOR Randomized Trial
7. Long-term Renal Function Outcomes After Stereotactic Ablative Body Radiotherapy for Primary Renal Cell Carcinoma Including Patients with a Solitary Kidney: A Report from the International Radiosurgery Oncology Consortium of the Kidney
8. Sarcopenia as a Predictor of Feeding Tube Placement in Individuals with Oropharyngeal Cancer
9. Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials
10. What is the predictive value of RECIST criteria following stereotactic lung radiation?
11. Transcriptional landscape of Kaposi sarcoma tumors identifies unique immunologic signatures and key determinants of angiogenesis
12. Management of Patients with Cardiovascular Implantable Electronic Devices Undergoing Radiation Therapy: A National Survey of Canadian Multidisciplinary Radiation Oncology Professionals
13. Whole organism profiling of the Timp gene family
14. Ensuring Superior Reporting of Radiation Therapy Noninferiority Trials: A Systematic Review
15. Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers
16. Does brachytherapy boost improve survival outcomes in Gleason Grade Group 5 patients treated with external beam radiotherapy and androgen deprivation therapy? A systematic review and meta-analysis
17. Systemic Nos2 Depletion and Cox inhibition limits TNBC disease progression and alters lymphoid cell spatial orientation and density
18. Can We Identify Predictors of Success in Contouring Education for Radiation Oncology Trainees? An Analysis of the Anatomy and Radiology Contouring Bootcamp
19. The Role of Ablative Radiotherapy in Older Adults With Limited Metastatic Disease
20. Toward a CRISPR-based mouse model of Vhl-deficient clear cell kidney cancer: Initial experience and lessons learned.
21. Exploitation of treatment induced tumor lysis to enhance the sensitivity of ctDNA analysis: A first-in-human pilot study
22. Circulating tumor cells detected in follow-up predict survival outcomes in tri-modality management of advanced non-metastatic esophageal cancer: a secondary analysis of the QUINTETT randomized trial
23. Surgical margins of the oral cavity: is 5 mm really necessary?
24. Endoscopic nodal staging in oligometastatic non-small cell lung cancer (NSCLC) being treated with stereotactic ablative radiotherapy (ENDO-SABR)
25. DART: diagnostic-CT-enabled planning: a randomized trial in palliative radiation therapy (study protocol)
26. Circulating tumor cells enumeration and characterization in patients with lung cancer treated with immunotherapy.
27. Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET)
28. Diagnostic CT-Enabled Planning (DART): Results of a Randomized Trial in Palliative Radiation Therapy
29. Implementation and evaluation of an online anatomy, radiology and contouring bootcamp for radiation therapists
30. Streamlining Clean Microgrid Economics: Multivariate Cost Optimization with Nuclear Power Integration
31. Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical study
32. Opioid therapy vs. multimodal analgesia in head and neck Cancer (OPTIMAL-HN): study protocol for a randomized clinical trial
33. Characterization and tissue localization of zebrafish homologs of the human ABCB1 multidrug transporter
34. Is ultra-hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? Early results from the HOPE Trial.
35. Expression of the transcription factor Klf6 by thymic epithelial cells is required for thymus development
36. Cost Optimization for Combined Small Modular Reactors and Renewables: A Genetic Algorithm-Based Approach
37. SAT179 Germline And Somatic Inactivating FLCN Variants In Parathyroid Cancer and Atypical Parathyroid Tumors
38. Long-Term Outcomes Following Fairly Brief Androgen Suppression and Stereotactic Radiation Therapy in High-Risk Prostate Cancer: Update From the FASTR/FASTR-2 Trials
39. 315: ARREST – A phase I study of SABR for poly-metastatic disease.
40. 83 Impact of the Covid-19 Pandemic on Academic Productivity in Oncology: A Journal-, Conference-and Author-Level Analysis
41. 20 Pneumonitis Risk Following Combined Osimertinib and Thoracic Radiotherapy in Egfr-Mutated Non-Small Cell Lung Cancer
42. 146 Five-Year Renal Function Outcomes After Sabr for Primary Renal Cell Carcinoma: A Report from the International Radiosurgery Oncology Consortium of the Kidney (IROCK)
43. 19 Predicting Esophagitis: A Secondary Analysis of the Palliative Radiation for Advanced Central Lung Tumours with Intentional Avoidance of the Esophagus (Proactive) Phase III Randomized Trial
44. 129 Assessment of Precision Irradiation in Early Non-Small Cell Lung Cancer and Interstitial Lung Disease (ASPIRE-ILD): Primary Analysis of a Phase II Trial
45. 56 Stereotactic Ablative Radiotherapy for Oligo-Progressive Cancers: Results of the Randomized Phase II Stop Trial
46. 112 Is Hypofractionated Whole-Pelvis Radiotherapy (WPRT) as Well Tolerated as Conventionally Fractionated WPRT in Prostate Cancer Patients? An Early Analysis of the Hope-Trial
47. Stereotactic Radiation Therapy in Early Non–Small Cell Lung Cancer and Interstitial Lung Disease: A Nonrandomized Clinical Trial
48. Detection of Circulating Tumor DNA After Stereotactic Ablative Radiotherapy in Patients With Unbiopsied Lung Tumors (SABR-DETECT)
49. 18F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure
50. Stereotactic Ablative radiotherapy before resection to avoid delay for early‐stage lung cancer or oligometastases during the COVID‐19 pandemic: Pathologic outcomes from the SABR‐BRIDGE protocol
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.